- 25 November, 2024
Netflix shares remain under pressure as inflation continues to rise
The U.S. reported this Wednesday that consumer prices rose sharply in April and drove the rate of inflation to the highest level in nearly 13
Ackman prefers Domino’s Pizza stock over Starbucks: Here’s why
Billionaire investor Bill Ackman said during The Wall Street Journal’s Future of Everything Festival on Wednesday that his hedge fund sold its entire stake in
Here’s why Array Technologies stock plunged 30% on Wednesday
Array Technologies (NASDAQ:ARRY), one of the world’s largest manufacturers of ground-mounting systems used in solar energy projects, was down by more than 33% as of
4 key takeaways from Wendy’s Q1 earnings report
Wendy’s Co. (NASDAQ: WEN) published its earnings report for the fiscal first quarter on Wednesday that topped Wall Street estimates. On the back of hawkish
Toyota Motor reports an over 100% growth in its Q4 net profit
Toyota Motor Corp. (LON: TYT) said on Wednesday its net profit in the fourth quarter posted an over 100% growth compared to last year as
Two pros discuss why tech stocks were hit hard on Monday
The fears of rising inflation that may push the Federal Reserve into tightening the monetary policy is weighing on the major Wall Street indices this
Is ARK Innovation ETF a buy after falling more than 30% from its highs?
ARK Innovation ETF had an incredible return over the past 12 months, but its price has weakened around 33% off its most recent high of
Why Callaway Golf, 3D Systems, and Ferro Corp are higher on Tuesday
The benchmark S&P 500 index and the Dow Jones Industrial Average tanked over 50 points and over 500 points, respectively, on Tuesday as rising inflation
Ginkgo Bioworks to go public in a $15B SPAC deal
Ginkgo Bioworks, a biotech company based in Boston, announced that it will go public via a merger with Soaring Eagle Acquisition Corp. (SRNG), a special
Here’s why Novavax stock fell again on Tuesday morning
Novavax Inc (NASDAQ: NVAX) delayed ramping up COVID-19 vaccine production again on Monday and said it was unlikely to seek regulatory approval for its shot